BRIAN WESTON: Open Payments
NPI 1144903220 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 36 payments from 8 companies in 2025. Trend: 2023 $1,096 · 2024 $1,779 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $282 |
| Insulet Corporation | 1 | $124 |
| Novo Nordisk Inc | 1 | $103 |
| Stryker Corporation | 1 | $82 |
| Boston Scientific Corporation | 1 | $25 |
| Curonix LLC | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
| Medtronic, Inc. | 1 | $14 |
Products named: RELISTOR, Omnipod, Ozempic, WaveWriter Alpha Prime 16, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, JOURNAVX, INTELLIS ADAPTIVESTIM.
Industry payments across LA — which companies pay providers there.
